Amarin Corp Plc (AMRN): Monthly English Prescribing Data (EPD) i...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Amarin Corp Plc (AMRN)

Reply Private New

Keep Last Read

Replies (5) Next 10 Prev Next

Send PM Follow Ignore

Followers	62
Posts	4445
Boards Moderated	0
Alias Born	04/23/2013

Re: None

Thursday, 09/19/2024 6:04:55 PM

Thursday, September 19, 2024 6:04:55 PM

Monthly English Prescribing Data (EPD) is provided by NHS England for all approved and reimbursed prescriptions. The portal for that data is found here:
https://opendata.nhsbsa.net/dataset/english-prescribing-data-epd

The data is recorded as individual doses. In the case of VAZKEPA® or the three other drugs that I track it would be individual capsules or tablets. The drugs that I track are:

• Icosapent ethyl (VAZKEPA®)
• OMEGA-3 FA EE (OMACOR)
• Bempedoic Acid (NEXLETOL)
• Bempedoic Acid + Ezetimibe (NEXLIZET) combo drug

This report contains data from Jan 2022 to Jul 2024. You may view and download the three slides here:
https://drive.google.com/file/d/19MAuuGeQgu5Hly7kB2qUfitO2SNwMkdF/view?usp=sharing

Summary:
Slide #1: Monthly Line Graph for Total Capsules/Tablets of each drug Jan 2022 – Jul 2024
Slide #2: Same as Slide #1 as a “stacked” cumulative column.
Slide #3: Table 1, VAZKEPA® Monthly Caps and the NHS Actual Price paid. Bar Graph: Quarterly

Keep Last Read

Replies (5) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent AMRN News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/01/2025 01:30:04 AM
Amarin Stock Surges 11% After $25 Million Licensing Deal with Recordati • IH Market News • 06/24/2025 02:09:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/24/2025 11:05:28 AM
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe • GlobeNewswire Inc. • 06/24/2025 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2025 11:05:23 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 11:05:10 AM
Amarin Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/07/2025 11:00:00 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2025 08:20:08 PM
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 04/29/2025 08:15:00 PM
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 • GlobeNewswire Inc. • 04/28/2025 08:15:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:09 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:09 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:07 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:06 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:05 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:05 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2025 01:00:03 AM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/11/2025 10:00:07 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2025 09:01:21 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2025 11:30:16 AM
Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2025 11:35:08 AM
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change • GlobeNewswire Inc. • 04/09/2025 11:30:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2025 11:25:08 AM
Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/07/2025 11:50:42 AM

More AMRN News

InvestorsHub NewsWire

A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM

Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM

Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM

A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM

Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM

Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow